tbuckley/cabot-search huggingface dataset:
Reply
Authors: Abdullah M.S. Al‐Osaimi, Stephen H. Caldwell
Journal: Hepatology (2006)

We thank Dr. Schartman for his comments and we appreciate the interest and the opportunity to clarify some of the points that they have raised. In our recent letter we examined 74 patients with nonalcoholic steatohepatitis (NASH) and cryptogenic cirrhosis (CC) and compared them to 45 patients with hepatitis C–related liver disease for the presence of a gaze abnormality, for which we coined the term "intermittent disconjugate gaze" or IDG.1 In the main study group, a history of alcohol consumption of more than 10 grams/day for females and 20grams/day for male was an exclusion criterion. Thus, Wernicke's encephalopathy is extremely unlikely. Three of the 12 (25%) patients with IDG had no cirrhosis and 3 of those with cirrhosis had no evidence of decompensation, making hepatic encephalopathy an unlikely explanation. Internuclear ophthalmoplegia (INO) is usually associated with a fixed impairment, in addition our patients were not patched ruling out INO and furthermore it is rarely described as fluctuating.2 In half of our patients, IDG could only be elicited after repetitive examination — a pattern which was reproducible in subsequent visits. Although atypical skew deviation was considered as a potential diagnosis, eight of our (75%) IDG patients did not have diplopia, and none had vertical gaze abnormalities, which are the central features of skew deviation.3-5 Intermittent incomitant horizontal (Strabismus) deviations6 was another consideration but only 3 of the IDG patient had diplopia, which is the sole symptom of this disorder. Two patients underwent single fiber electromyography and another patient had a negative anti-acetylcholine receptor antibodies rendering myasthenia unlikely. We hypothesized that mitochondrial injury may be the link between this disorder and NASH/CC. Further studies are needed to dispute or validate this hypothesis. However, mitochondrial heteroplasmy could explain variable susceptibility to oxidative stress in different tissues.7-9 Moreover, the presence of mitochondrial dysfunction in the skeletal muscle of the insulin resistance offspring of patients with type 2 diabetes supports a role of this organelle in the closely related disorder of NAFLD.10 However, we assert that our report is an initial descriptive study of a unique and unreported ophthalmological finding in patients with nonalcoholic fatty liver disease. The precise etiology of this finding remains the subject of speculation. Abdullah M.S. Al-Osaimi*, Stephen H. Caldwell*, * University of Virginia Health System Charlottesville, VA.
Investigation of Anthrax Associated With Intentional Exposure and Interim Public Health Guidelines, October 2001
Journal: JAMA (2001)

and local public health authorities reported a case of inhalational anthrax in Florida. 1 Additional cases of anthrax subsequently have been reported from Florida and New York City.This report updates the findings of these case investigations, which indicate that infections were caused by the intentional release of Bacillus anthracis.This report also includes interim guidelines for postexposure prophylaxis for prevention of inhalational anthrax and other information to assist epidemiologists, clinicians, and laboratorians responding to intentional anthrax exposures.For these investigations, a confirmed case of anthrax was defined as (1) a clinically compatible case of cutaneous, inhalational, or gastrointestinal illness * that is laboratory confirmed by isolation of B. anthracis from an affected tissue or site or ( 2) other laboratory evidence of B. anthracis infection based on at least two supportive laboratory tests.A suspected case was defined as (1) a clinically compatible case of illness without isolation of B. anthracis and no alternative diagnosis, but with laboratory evidence of B. anthracis by one supportive laboratory test or (2) a clinically compatible case of anthrax epidemiologically linked to a confirmed environmental exposure, but without corroborative laboratory evidence of B. anthracis infection.Laboratory criteria for diagnosis of anthrax consist of (1) isolation and confirmation of B. anthracis from a clinical specimen collected from an affected tissue or site or (2) other supportive laboratory tests, including (a) evidence of B. anthracis DNA by polymerase chain reaction (PCR) from specimens collected from an affected tissue or site, (b) demonstration of B. anthracis in a clinical specimen by immunohistochemical staining, or (c) other laboratory tests (e.g., serology) that may become validated by laboratory confirmation.Florida On October 2, the Palm Beach County Health Department (PBCHD) and the Florida Department of Health (FDOH) were notified of a possible anthrax case in Palm Beach County.The suspected case was identified when a gram stain of cerebrospinal fluid (CSF) revealed gram-positive bacilli.An epidemiologic investigation was initiated by FDOH, PBCHD, and the FDOH state laboratory.The state laboratory and CDC confirmed B. anthracis from a culture of CSF on October 4. Later the same day, FDOH and CDC epidemiologists * Ciprofloxacin dosage should not exceed 1 g/d in children.Ciprofloxacin, 500 mg twice per d by mouth Doxycycline, 100 mg twice per d by mouth or or 60 Children Ciprofloxacin, 10-15 mg/kg every 12 h by mouth * Doxycycline Aged >8 y and >45 kg: 100 mg twice per d by mouth Aged >8 y and ≤45 kg: 2.2 mg/kg twice per d by mouth Aged ≤8 y: 2.2 mg/kg twice per d by mouth 60
Books Received
Journal: JAMA (1907)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Family Practice
Authors: Nicholas J. Pisacano
Journal: JAMA (1980)

As the specialty of family practice entered its second decade this past year, the leadership—which is made up of representatives from the American Academy of Family Physicians, the American Board of Family Practice, the Family Health Foundation of America, and the Society of Teachers of Family Medicine (and which is euphemistically known as the "Family")—withdrew briefly into a "retreat" atmosphere to pause and view ourselves critically. It became apparent that family practice is no longer the "new kid on the block." We saw things that made us<i>proud</i>; with deeper introspection, we found much to make us humble. <h3>We Are Proud of...</h3> It is with pride that we approach the 400-mark in number of accredited residency programs; nearly 7,000 residents are in training. Our academic arm is fairly strong, and the specialty still captures the interest of the major portion of medical students; interestingly enough, the students who enter family
NECROLOGY.
Journal: JAMA (1891)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Wet Combing for Head Lice: Feasibility in Mass Screening, Treatment Preference and Outcome
Authors: R H Vander Stichele, L Gyssels, C Bracke, F Meersschaut, I Blokland, E Wittouck, S Willems, J De Maeseneer
Journal: Journal of the Royal Society of Medicine (2002)

There is no scientific consensus on the best way to control head louse infestation in schoolchildren. A study was conducted to test the feasibility and acceptability of a screening campaign by wet combing and a community approach to head-louse control with home visits, and to explore parents’ treatment preferences and treatment outcomes. A non-controlled intervention (advice on treatment options offered to all positive children) was nested within an epidemiological prevalence study. All children in three primary schools in Ghent, Belgium, were invited to take part in screening by wet combing (n=677, 3–11 years). Positive children were offered structural treatment advice, a home visit on day 7, and a check by wet combing on day 14. 83% of the children were screened. The prevalence of active infestation (living moving lice) was 13.0% in school 1 and 19.5% in school 3. In school 2, prevalence of signs of active and past infestation was 40.7%. A home visit was made to 58% of the positive children. 85% of the positive children were screened again on day 14. Wet combing was the most widely used treatment, followed by chemical treatment and a combination of the two. In school 1 and 3 51% were cured, and in school 2 24% became nit-free. A wet combing screening campaign and a community-oriented approach to head-louse control is feasible though resource-intensive. The prevalence of head lice was high and the cure rate was low, with either topical treatments or wet combing.
A LARGE SUPPURATING ABDOMINAL CYST
Journal: JAMA (1988)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Incorrect Colors in Figure Keys
Journal: JAMA Internal Medicine (2018)

Gillian E. Caughey, PhD; Genevieve M. Gabb, MBBS, MPH; Saffron Ronson, BPharm (Hons); Michael Ward, PhD; Timothy Beukelman, MD, MSCE; Catherine L. Hill, MBBS; Vidya Limaye, MBBS, PhD
ITALY
Journal: JAMA (1930)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
New alternatives in the N.H.S. I. Economic benefits of restrictions on clinical freedom.
Authors: M Bott, A Cav- Enagh, Hugh Dudley, . Forsythe, R Hardy, D Kerr, Mr Klein, S Lock, De- Puty Editor, G Macpherson, Noel Olsen, Philip Rhodes, N Shinton, Warwickshire Hospital, A Smith, M Ware, W Waters
Journal: BMJ (1974)

On 5-6 October the B.M.J. held a conference in Winchester of 14 invited spseakers to consider "New Alternatives in the N.H.S."The theme underlying this mnAeting was that the N.H.S. is likely to
A cyclooxygenase-2 (COX-2) inhibitor compared with dexamethasone in a survival study of rats with intracerebral 9L gliosarcomas
Authors: Jana Portnow, Samia Suleman, Stuart A. Grossman, Susan Eller, Kathryn Carson
Journal: Neuro-Oncology (2002)

Neuro-OncologyAlthough dexamethasone is very effective for controlling peritumoral cerebral edema, it is associated with distressing side effects that decrease the quality of life for many patients.One potential mechanism to explain the ability of dexamethasone to repair blood-brain barrier dysfunction is through the inhibition of cyclooxygenase-2 (COX-2).The purpose of this study was to determine in a rat brain tumor model whether SC-236, a selective COX-2 inhibitor, is as effective as dexamethasone.Twenty-nine adult male Fischer 344 rats were implanted with intracerebral 9L gliosarcomas and divided into 3 treatment groups.One group (n = 9) served as controls, another (n = 9) was treated with dexamethasone (3 mg/kg p.o. daily), and a third group (n = 11) received SC-236 (3 mg/kg p.o. daily).A survival study was performed.The median survival in the control group was 16 days, compared with 23 days for the dexamethasone group and 23 days for the COX-2 inhibitor group.Kaplan-Meier analysis on pairwise group comparisons showed improved survival that was statistically signi cant for each treatment group compared with the control group (log-rank test P = 0.009 for dexamethasone to control and P = 0.005 for COX-2 to control), and no signi cant difference in survival for the COX-2 compared with dexamethasone (log-rank
Natural Language Processing to Assess Frequency of Functional Status Documentation for Patients Newly Diagnosed With Colorectal Cancer—Reply
Authors: Nicole D. Agaronnik, Charlotta Lindvall, Lisa I. Iezzoni
Journal: JAMA Oncology (2021)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Oncology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Oncology journal
ARMAND GAUTIER AND PTOMAINS
Journal: JAMA (1921)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Rapid Fire ‐ Clinical 3
Authors: R De, La Espriella-Juan, ; Ppilar Garcia-Gonzalez, ; Cozar-Santiago, ; Fabregat-Andres, ; Estornell-Erill, ; Bochard-Villanueva, ; Cubillos-Arango, ; Morell-Cabedo, Francisco Ridocci-Soriano, J Lupon, M De, E Zamora, M Domingo, Urrutia Gonzalez, C Diez, ; Coll, A Bayes-Genis, K Zykov
Journal: European Journal of Heart Failure (2014)
Correction: Fluid deprivation due to Althesin solution affecting drop size
Authors: W Rayner, D Ritchie, P Stark
Journal: BMJ (1980)

Diabetic control was very difficult.Avoiding confrontation by giving the patient responsibility for both her eating and managing her diabetes merely resulted in further weight loss.After seven months she discharged herself weighing 46 kg.Four months later her pattern of eating remained disturbed.She was not testing her urine but her weight had increased to 49 kg.(2) This patient developed diabetes when aged 13 years.Her management was complicated by a fear of injections and occasional dietary indiscretions.At 16 she started to diet and over six months her weight fell by 14 kg to 38-2 kg (standard weight 50 3 kg).She reduced her insulin from 92 to 16 units/day in order to accommodate to the low carbohydrate intake.Menstruation ceased.She talked of feelings of intense guilt whenever she had glyco- suria.On admission to a psychiatric hospital her weight was 39 4 kg.This increased steadily with a behavioural management programme.After 12 weeks her weight was 48-5 kg.Now, one year after discharge, her weight remains satisfactory, but she is still preoccupied with food and eating and remains amenorrhoeic.(3) This patient developed diabetes when aged 17 years.She found the dietary restrictions difficult to accept but her managementwas straightforward.At 23 she narrowly escaped serious injury in a road traffic accident.After this and a broken engagement she began to have difficulty swallowing.Soon she took only fluids, her weight fell from 62 kg to 46 kg (standard weight 64 kg), and she ceased menstruating.Physical investigations were unremark- able and diabetic control remained satisfactory.Reluctantly she accepted admission to a psychiatric hospital.Her difficulty in swallowing rapidly resolved and her weight increased over two months to 49-9 kg.Since discharge her weight has increased and diabetic control remains satisfactory.3 Stillians AW.The control of localized hyperhidrosis.
Contents
Authors: Philip Chen, Shan Lin, Anna Junk, Sunita Radhakrishnan, Kuldev Singh, Teresa Chen, Paula Newman-Casey, Alan Robin, Taylor Blachley, Karen Farris, Michele Heisler, Ken Resnicow, Paul Lee, Zhongheng Wu, Guihua Xu, Robert Weinreb, Marco Yu, Christopher Leung, Anastasia Pilat, Daniel Sibley, Rebecca Mclean, Frank Proudlock, Irene Gottlob, Imre Lengyel, Adrienne Csutak, Daniela Florea, Irene Leung, Alan Bird, Fridbert Jonasson, Sajjad Mahmood, Stephen Frcophth, Tariq Roberts, Jeremy Parkes, Kate Barugh, B Hons, Paul Bishop, Moritz Lindner, Alexander Böker, Matthias Mauschitz, Arno Göbel, Rolf Fimmers, Christian Brinkmann, Steffen Schmitz-Valckenberg, Matthias Schmid, Frank Holz, Monika Fleckenstein, Fundus Autofluorescence, Saskia Van Romunde, Antonio Polito, Laura Bertazzi, Massimo Guerriero, Grazia Pertile, Arup Das, Paul Mcguire, Sampathkumar Rangasamy, Raafay Sophie, Na Lu, Peter Campochiaro, Sumit Sharma, Careen Lowder, Amit Vasanji, Kimberly Baynes, Peter Kaiser, Sunil Srivastava, Tanya Glaser, Lauren Doss, Grace Shih, Divya Nigam, Robert Sperduto, Frederick Ferris, Elvira Agrón, Traci Clemons, Emily Chew, Chin-Te Huang, Shao-Yin Chu, Yuan-Chieh Lee, Touka Banaee, Giovanni Staurenghi, Rick Spaide, Yaniv Barkana, Syril Dorairaj, Yih-Chung Tham, Ching-Yu Hons, Colin Tan, Kai Cheong, Louis Lim
Journal: Ophthalmology (2015)
START (Active Surveillance or Radical Treatment for newly diagnosed patients with a localized, low risk, prostate cancer): an epidemiological study of the Oncology Network of Piemonte and Valle d'Aosta
Authors: M. Mistrangelo, C. Galassi, M. Ceccarelli, C. Monagheddu, E. Pagano, R. Rosato, P. Ivaldi, E. Bollito, A. Zitella, S. De Luca, M. Camilli, F. Munoz, A.R. Bellissimo, F. Bongiovanni, M. Dell'Aquila, F. Ponti di Sant'Angelo, G. Ciccone, O. Bertetto
Journal: Annals of Oncology (2016)
Medical Economics
Journal: JAMA (1913)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal